1. ScholarBank@NUS
  2. 1. Staff
  3. Staff Publications
Please use this identifier to cite or link to this item: https://doi.org/10.4155/fsoa-2017-0050
DC FieldValue
dc.titleCombined-modality hypofractionated radiotherapy for elderly patients with glioblastoma: Setting a new standard
dc.contributor.authorVellayappan, B.A
dc.contributor.authorHalasz, L.M
dc.contributor.authorKnisely, J.P
dc.contributor.authorChang, E.L
dc.contributor.authorLo, S.S
dc.date.accessioned2020-10-21T08:05:29Z
dc.date.available2020-10-21T08:05:29Z
dc.date.issued2017
dc.identifier.citationVellayappan, B.A, Halasz, L.M, Knisely, J.P, Chang, E.L, Lo, S.S (2017). Combined-modality hypofractionated radiotherapy for elderly patients with glioblastoma: Setting a new standard. Future Science OA 3 (3) : FSO210. ScholarBank@NUS Repository. https://doi.org/10.4155/fsoa-2017-0050
dc.identifier.issn20565623
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/178715
dc.description.abstract[No abstract available]
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceUnpaywall 20201031
dc.subjectbevacizumab
dc.subjectlomustine
dc.subjectmethylated DNA protein cysteine methyltransferase
dc.subjecttemozolomide
dc.subjectcancer growth
dc.subjectcancer radiotherapy
dc.subjectclinical trial (topic)
dc.subjectelderly care
dc.subjectglioblastoma
dc.subjecthuman
dc.subjectmethylation
dc.subjectmultimodality cancer therapy
dc.subjectoverall survival
dc.subjectpriority journal
dc.subjectrandomized controlled trial (topic)
dc.subjectReview
dc.typeReview
dc.contributor.departmentMEDICINE
dc.description.doi10.4155/fsoa-2017-0050
dc.description.sourcetitleFuture Science OA
dc.description.volume3
dc.description.issue3
dc.description.pageFSO210
Appears in Collections:Elements
Staff Publications

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_4155_fsoa-2017-0050.pdf1.12 MBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons